Related Experiment Video

Updated: Jul 18, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Tumor antigens as surrogate markers and targets for therapy and vaccines

Angus Dalgleish1, Hardev Pandha

  • 1St. George's University of London, Cranmer, London SW17 0RE, United Kingdom.

Advances in Cancer Research
|December 13, 2006
PubMed

Insights

Hundreds of new tumor-associated antigens (TAAs) offer promising targets for cancer therapies and diagnostics. These antigens are crucial for developing effective antibody and vaccine treatments, improving patient outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Numerous tumor antigens exist, including tumor-specific antigens and tumor-associated antigens (TAAs).
  • Recent advancements have led to the identification of hundreds of novel TAAs.
  • TAAs are critical in cancer biology and therapeutic targeting.

Purpose of the Study:

  • To highlight the significance of TAAs as therapeutic targets in cancer.
  • To discuss the role of TAAs in the development of passive and active immunotherapies.
  • To explore the utility of TAAs as diagnostic and prognostic markers.

Main Methods:

  • Review of recent literature on tumor antigen identification and characterization.
  • Analysis of clinical trial data for antibody-based therapies targeting tumor antigens.
  • Evaluation of TAAs as biomarkers for cancer diagnosis and treatment monitoring.

Main Results:

  • Hundreds of new TAAs have been identified, expanding the landscape of potential cancer targets.
  • Antibody-based therapies targeting tumor-specific antigens (e.g., Herceptin, Cetuximab) have shown clinical efficacy.
  • TAAs serve as valuable surrogate markers for cancer diagnosis and assessing treatment response.

Conclusions:

  • TAAs represent a rich source of targets for novel cancer therapies, including antibody and vaccine-based approaches.
  • The identification and characterization of TAAs are pivotal for advancing precision oncology.
  • TAAs play a dual role in cancer management, aiding both treatment and patient monitoring.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...